What's New
Mifeprex (mifepristone) - Revisions to the BOXED WARNING, WARNINGS, MEDICATION GUIDE, and PATIENT AGREEMENT sections of the prescribing information, describing serious and sometimes fatal infections and bleeding that may occur following the use of Mifeprex.
(Posted 11/15/2004)
Humira (adalimumab) - Revisions to the WARNINGS section of the prescribing information to include reports of serious infections, hypersensitivity reactions, pancytopenia and aplastic anemia.
(Posted 11/08/2004)
Actra-Rx and Yilishen dietary supplements - FDA warned consumers not to purchase or to consume Actra-Rx or Yilishen, dietary supplements which contain the prescription drug ingredient sildenafil. The interaction between sildenafil and certain prescription drugs may cause a significant lowering of blood pressure to an unsafe level.
(Posted 11/4/2004)
|